Helen M. Boudreau - Insider Trading & Ownership

Location: 200 Technology Square, 4 Th Floor, Cambridge, MA
Summary: The estimated net worth of Helen M. Boudreau is at least $142K dollars as of November 26, 2025. Helen M. Boudreau is the Director of Cara Therapeutics, Inc. and owns shares of Tvardi Therapeutics, Inc. (TVRD) stock worth about $113K. Helen M. Boudreau is the Director of Rallybio Corp and owns shares of Rallybio Corp (RLYB) stock worth about $29.2K.
Signature: /s/ David L. Klatsky, Attorney-in-fact
All Insider Reports: All Insider Reports

Notify me when Helen M. Boudreau files a new Insider Trading report.

Ownership of Helen M. Boudreau

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
TVRD	Tvardi Therapeutics, Inc.	Director	$113K			Jun 4, 2024
RLYB	Rallybio Corp	Director	$29.2K			May 13, 2025
PINC	Premier, Inc.	Director	$0	-$99.3K	-100%	Nov 25, 2025
STTK	Shattuck Labs, Inc.	Director				Jul 14, 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.